Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Mallbris · SciRah

Researcher profile · Semantic Scholar

L. Mallbris

Share profile

L. Mallbris — researcher profile on SciRah

h-index: 44
Works: 117
Citations: 7,862

Most-cited papers

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
A. Strange, F. Capon, C. Spencer, J. Knight +80 more
2010Nature Genetics1,046 citations Open access
Semantic Scholar
Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity
L. Tsoi, S. Spain, J. Knight, E. Ellinghaus +196 more
2012Nature Genetics714 citations Open access
Semantic Scholar
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
K. Gordon, A. Blauvelt, K. Papp, R. Langley +16 more
2016New England Journal of Medicine468 citations Open access
Semantic Scholar
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
R. Bissonnette, K. Papp, Y. Poulin, M. Gooderham +7 more
2016British Journal of Dermatology416 citations Open access
Semantic Scholar
Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis.
Katarina Wolk, L. Mallbris, P. Larsson, A. Rosenblad +2 more
2009Acta Dermato-Venereologica177 citations Open access
Semantic Scholar
The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
E. Simpson, R. Bissonnette, L. Eichenfield, E. Guttman-Yassky +33 more
2020Journal of American Academy of Dermatology165 citations
Semantic Scholar
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
K. Papp, J. Krueger, S. Feldman, R. Langley +11 more
2016Journal of American Academy of Dermatology149 citations Open access
Semantic Scholar
Tofacitinib withdrawal and retreatment in moderate‐to‐severe chronic plaque psoriasis: a randomized controlled trial
R. Bissonnette, L. Iversen, H. Sofen, C. Griffiths +10 more
2015British Journal of Dermatology148 citations
Semantic Scholar
Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study
A. Egeberg, L. Mallbris, R. B. Warren, H. Bachelez +3 more
2016British Journal of Dermatology146 citations
Semantic Scholar
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
A. Egeberg, L. Mallbris, G. Gislason, L. Skov +1 more
2015Journal of Investigative Dermatology128 citations Open access
Semantic Scholar
Short‐ and long‐term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
B. Strober, C. Leonardi, K. Papp, U. Mrowietz +12 more
2017Journal of American Academy of Dermatology127 citations Open access
Semantic Scholar
The relationship between duration of psoriasis, vascular inflammation and cardiovascular events
A. Egeberg, L. Skov, A. Joshi, L. Mallbris +7 more
2017Journal of American Academy of Dermatology112 citations Open access
Semantic Scholar
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)
K. Papp, C. Leonardi, A. Blauvelt, K. Reich +9 more
2018British Journal of Dermatology90 citations Open access
Semantic Scholar
Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa.
A. Egeberg, G. Jemec, A. Kimball, H. Bachelez +3 more
2017Journal of Investigative Dermatology88 citations Open access
Semantic Scholar
Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
P. Nordenfelt, S. Dawson, C. Wahlgren, A. Lindfors +2 more
2014Allergy and Asthma Proceedings86 citations
Semantic Scholar
Incidence and Prevalence of Psoriasis in Denmark.
A. Egeberg, L. Skov, G. Gislason, J. Thyssen +1 more
2017Acta Dermato-Venereologica84 citations Open access
Semantic Scholar
Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
B. Kirkham, K. de Vlam, Wen-Zhi Li, R. Boggs +3 more
2015Clinical and Experimental Rheumatology78 citations
Semantic Scholar
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.
A. Svedbom, J. Dalén, C. Mamolo, J. Cappelleri +3 more
2015Acta Dermato-Venereologica74 citations Open access
Semantic Scholar
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study
A. Egeberg, L. Kristensen, J. Thyssen, G. Gislason +7 more
2017Annals of the Rheumatic Diseases73 citations Open access
Semantic Scholar
Risk of periodontitis in patients with psoriasis and psoriatic arthritis
A. Egeberg, L. Mallbris, G. Gislason, P. Hansen +1 more
2017Journal of the European Academy of Dermatology and Venereology73 citations
Semantic Scholar
Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study.
A. Egeberg, U. Khalid, G. Gislason, L. Mallbris +2 more
2015JAMA dermatology73 citations Open access
Semantic Scholar
Herpes zoster in psoriasis patients treated with tofacitinib
K. Winthrop, M. Lebwohl, A. Cohen, J. Weinberg +9 more
2017Journal of American Academy of Dermatology67 citations
Semantic Scholar
Injury downregulates the expression of the human cathelicidin protein hCAP18/LL‐37 in atopic dermatitis
L. Mallbris, Lina M. Carlén, T. Wei, J. Heilborn +3 more
2010Experimental Dermatology67 citations
Semantic Scholar
Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three‐year results from the UNCOVER‐3 study
C. Leonardi, C. Maari, S. Philipp, O. Goldblum +7 more
2018Journal of American Academy of Dermatology66 citations
Semantic Scholar
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis
A. Blauvelt, K. Papp, H. Sofen, M. Augustin +10 more
2017Journal of the European Academy of Dermatology and Venereology66 citations Open access
Semantic Scholar
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
S. Feldman, D. Thaçi, M. Gooderham, M. Augustin +8 more
2016Journal of American Academy of Dermatology66 citations
Semantic Scholar
Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma.
M. Hedblad, L. Mallbris
2012Journal of American Academy of Dermatology64 citations
Semantic Scholar
Systematic review on rapidity of onset of action for interleukin‐17 and interleukin‐23 inhibitors for psoriasis
A. Egeberg, Y. Andersen, A.-S. Halling-Overgaard, Farzad Alignahi +3 more
2019Journal of the European Academy of Dermatology and Venereology62 citations
Semantic Scholar
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate‐to‐severe plaque psoriasis: Results from UNCOVER‐1, UNCOVER‐2, and UNCOVER‐3
A. Egeberg, Jashin J. Wu, N. Korman, J. Solomon +3 more
2018Journal of American Academy of Dermatology60 citations
Semantic Scholar
Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies
A. Gottlieb, J. Lacour, N. Korman, S. Wilhelm +6 more
2016Journal of the European Academy of Dermatology and Venereology58 citations Open access
Semantic Scholar
HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study
L. Mallbris, Katarina Wolk, Fabio Sánchez, M. Ståhle
2009BMC Dermatology54 citations Open access
Semantic Scholar
Risk of self‐harm and nonfatal suicide attempts, and completed suicide in patients with psoriasis: a population‐based cohort study
A. Egeberg, P. Hansen, G. Gislason, L. Skov +1 more
2016British Journal of Dermatology52 citations
Semantic Scholar
Infections from seven clinical trials of ixekizumab, an anti‐interleukin‐17A monoclonal antibody, in patients with moderate‐to‐severe psoriasis
K. Papp, H. Bachelez, A. Blauvelt, K. Winthrop +9 more
2017British Journal of Dermatology49 citations Open access
Semantic Scholar
Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study
A. Egeberg, U. Khalid, G. Gislason, L. Mallbris +2 more
2016Journal of Clinical Sleep Medicine (JCSM)44 citations Open access
Semantic Scholar
The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised, controlled Phase 3 studies of patients with moderate‐to‐severe plaque psoriasis
K. Reich, L. Puig, L. Mallbris, L. Zhang +2 more
2017Journal of the European Academy of Dermatology and Venereology41 citations
Semantic Scholar
Increased risk of migraine in patients with psoriasis: A Danish nationwide cohort study.
A. Egeberg, L. Mallbris, Gunnar Hilmar Gislason, L. Skov +1 more
2015Journal of American Academy of Dermatology41 citations
Semantic Scholar
Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A)
K. Duffin, J. Bagel, M. Bukhalo, I. J. Mercado Clement +7 more
2016Journal of the European Academy of Dermatology and Venereology40 citations Open access
Semantic Scholar
Impact of Depression on Risk of Myocardial Infarction, Stroke and Cardiovascular Death in Patients with Psoriasis: A Danish Nationwide Study.
A. Egeberg, U. Khalid, G. Gislason, L. Mallbris +2 more
2016Acta Dermato-Venereologica40 citations Open access
Semantic Scholar
Psoriasis beyond the skin: a review of the literature on cardiometabolic and psychological co-morbidities of psoriasis
L. Puig, B. Kirby, L. Mallbris, R. Strohal
2014EJD. European journal of dermatology40 citations
Semantic Scholar
Long-term Outcomes and Prognosis in New-Onset Psoriasis.
A. Svedbom, L. Mallbris, P. Larsson, P. Nikamo +6 more
2021JAMA dermatology39 citations Open access
Semantic Scholar
The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA
J. Walsh, H. Jones, L. Mallbris, K. Duffin +3 more
2018Psoriasis37 citations Open access
Semantic Scholar
Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis
Y. Andersen, M. Augustin, J. Petersen, K. Hagenström +3 more
2019British Journal of Dermatology36 citations
Semantic Scholar
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
A. Blauvelt, K. Papp, C. Griffiths, L. Puig +6 more
2017American Journal of Clinical Dermatology35 citations Open access
Semantic Scholar
Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis.
A. Svedbom, L. Mallbris, Á. González-Cantero, M. Playford +3 more
2024JAMA dermatology28 citations Open access
Semantic Scholar
A higher score on the dermatology life quality index, being on systemic treatment and having a diagnosis of psoriatic arthritis is associated with increased costs in patients with plaque psoriasis.
M. Ekelund, L. Mallbris, S. Qvitzau, B. Stenberg
2013Acta Dermato-Venereologica28 citations Open access
Semantic Scholar
Hereditary Angioedema in Swedish Adults: Report From the National Cohort.
P. Nordenfelt, M. Nilsson, J. Björkander, L. Mallbris +2 more
2016Acta Dermato-Venereologica27 citations Open access
Semantic Scholar
Cornulin, a marker of late epidermal differentiation, is down‐regulated in eczema
A. Liedén, Elisabeth Ekelund, I. Kuo, Ingrid Kockum +13 more
2009Allergy. European Journal of Allergy and Clinical Immunology27 citations
Semantic Scholar
Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis
C. Griffiths, R. Vender, H. Sofen, L. Kircik +5 more
2016Journal of the European Academy of Dermatology and Venereology26 citations Open access
Semantic Scholar
Association between depression and risk of atrial fibrillation and stroke in patients with psoriasis: a Danish nationwide cohort study
A. Egeberg, U. Khalid, G. Gislason, L. Mallbris +2 more
2015British Journal of Dermatology26 citations Open access
Semantic Scholar
Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
C. Leonardi, Kyoungah See, G. Gallo, M. Mckean-Matthews +4 more
2021Dermatologic Therapy25 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Egeberg×14
Invite
A. Egeberg — researcher profile on SciRah
G. Gislason×12
Invite
G. Gislason — researcher profile on SciRah
L. Skov×11
Invite
L. Skov — researcher profile on SciRah
K. Papp×8
Invite
K. Papp — researcher profile on SciRah

×7

Invite

M. Ståhle — researcher profile on SciRah

Invite

P. Hansen — researcher profile on SciRah

Invite

A. Blauvelt — researcher profile on SciRah

Invite

M. Ohtsuki — researcher profile on SciRah

Invite

K. Reich — researcher profile on SciRah

Invite

C. Leonardi — researcher profile on SciRah

Katarina Wolk×4

Invite

Katarina Wolk — researcher profile on SciRah

C. Griffiths×4

Invite

C. Griffiths — researcher profile on SciRah